Archives for April 25, 2004

← 2004

Rhodia makes €400m from divestments

French chemicals company Rhodia has announced three new deals which keep it on track to divest €700 million-worth of businesses by the end of the year as it aims for a return to profitability in 2006.

Swedish intelligent packaging trials underway

Swedish company Cypak has started two trials of its Intelligent Pharmaceutical Packaging (IPP) technology, which offers an alternative to radiofrequency identification (RFID) for tracking the use of medicines.

Research reveals scale of child-proof packaging problems

Designers of child-proof packaging must always work against the paradox that a package which is hard for a child to open can often also be difficult for the adult patient it is intended to treat. In fact, up to 90 per cent of adults struggle to open...

GM bacteria used as cancer treatment

Researchers in the UK have devised a means of using bacteria as a means of delivering proteins into tumour cells and killing them, raising the hope that this could form the basis of a new treatment for cancer.

Safety syringe goes into production

US company Globe Medical Tech has started production of a new type of safety syringe developed by Maxxon that should cost no more than a regular, non-safe disposable syringe.

Sanofi-Aventis looks likely as Novartis ducks out

Switzerland's Novartis has decided to withdraw from any negotiations with Aventis over a possible merger, after official discussions with the latter and fellow French-based company Sanofi-Synthelabo got underway.